Trial intelligence / Profile preview

OZ439 and Piperaquine Phosphate PK in Healthy Subjects

NCT02083406Phase 1Completed

Sponsor
Medicines for Malaria Venture
Start
Jul 2014
Primary completion
Jul 2014
Countries
1
01

Overview

Phase 1, randomised, open-label trial of artefenomel in malaria, sponsored by Medicines for Malaria Venture. Started Jul 2014; status: completed.

02

Drugs

artefenomel
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02083406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02083406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call